Abstract
Abstract Background: There is no effective therapy for many neurological disorders associated with significant neurological damage such as kernicterus. Patients with Kernicterus (Chronic bilirubin encephalopathy) which is a neurological dysfunction resulting from exposure of the brain to severe hyperbilirubinemia mostly during the neonatal period continue to experience significant disability. There is no known therapeutic intervention that can obviously improve this condition. The aim of this paper is to describe a novel therapeutic approach which in two months produced marked improvement of the neurological dysfunction caused by kernicterus. Patients and methods: A girl with kernicterus were not speaking and not saying any word. She was lacking the balance (co-ordination) without obvious muscle weakness. She was unable to maintain the sitting posture on a chair for few minutes. She was unable to maintain straight standing posture when supported on chair at all. She had difficulty in holding things. The girl was treated with a novel therapeutic approach including two courses of intramuscular cerebrolysin and intramuscular citicoline. Results: After treatment the first month of treatment, speech development was initiated and she was saying few words. She was able to sit normally on the chair and maintaining the sitting posture indefinitely. She was able to maintain more straight stable standing posture without holding a chair and with the ability to hold things at the same time indicting improved coordination. She also developed improved ability to hold small things like a pen. After the second month of treatment, the girl was able to stand alone and was making few steps slowly holding furniture. After treatment the second course of treatment, the girl was able to stand alone and walk rapidly holding furniture. Treatment was not associated with any side effects. Conclusion: The novel use of intramuscular cerebrolysin and citicoline in a patient with kernicterus was safe and effective.
Reference7 articles.
1. 1. Brodersen R. Prevention of kernicterus, based on recent progress in bilirubin chemistry. Acta Paediatr Scand. 1977; 66: 625-634.
2. 2. Gourley GR. Bilirubin metabolism and kernicterus. Adv Pediatr. 1997; 44: 173-229.
3. 3. Al-Mosawi AJ. A novel therapeutic approach for the treatment of brain atrophy. 1st ed. Saarbrücken; LAP Lambert Academic Publishing: 2018.
4. 4. Al-Mosawi AJ. A novel therapeutic approach for idiopathic mental retardation. 1st ed. Saarbrücken; LAP Lambert Academic Publishing: 2018.
5. 5. Al-Mosawi AJ. The use of cerebrolysin and citicoline in autism and Asperger syndrome. J Bio Innov. 2019; 8: 99-108.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Novel Therapeutic Approach for Treating Rett Syndrome.;SunKrist Neurology, Neurosurgery and Stroke Journal;2021-03-03